Comerica Bank’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$894 Sell
224
-742
-77% -$4.13K ﹤0.01% 3592
2025
Q3
$8.17K Buy
966
+732
+313% +$7.1K ﹤0.01% 3294
2025
Q2
$2.63K Sell
234
-5,416
-96% -$49.7K ﹤0.01% 3469
2025
Q1
$53.5K Sell
5,650
-494
-8% -$4.99K ﹤0.01% 2767
2024
Q4
$69.1K Sell
6,144
-47,614
-89% -$837K ﹤0.01% 2716
2024
Q3
$1.52M Sell
53,758
-7,250
-12% -$187K 0.01% 1300
2024
Q2
$1.17M Sell
61,008
-3,350
-5% -$85.5K ﹤0.01% 1403
2024
Q1
$2.11M Sell
64,358
-1,144
-2% -$36.5K 0.01% 1142
2023
Q4
$2.16M Buy
65,502
+285
+0.4% +$8.06K 0.01% 1118
2023
Q3
$1.78M Buy
65,217
+38,912
+148% +$1.08M 0.01% 1146
2023
Q2
$0 Buy
+26,305
New +$851K ﹤0.01% 809
2022
Q4
$1.61M Hold
52,319
0.01% 1204
2022
Q3
$1.61M Buy
52,319
+6,319
+14% +$223K 0.01% 1178
2022
Q2
$1.5M Hold
46,000
0.01% 1286
2022
Q1
$1.4M Buy
+46,000
New +$1.2M 0.01% 1387
2021
Q2
Sell
-55,605
Closed -$1.13M 2346
2021
Q1
$1.13M Buy
55,605
+1,117
+2% +$21.2K 0.01% 1702
2020
Q4
$1.02M Sell
54,488
-2,498
-4% -$33K 0.01% 1710
2020
Q3
$627K Buy
+56,986
New +$670K ﹤0.01% 1811

Other funds holding EVH

Comerica Bank's EVH Position: Q4 2025 in Review

Comerica Bank reduced its Evolent Health (EVH) stake by 77% in Q4 2025, selling an estimated $4.13K and leaving 224 shares worth $894. The position accounts for ﹤0.01% of the portfolio, ranked #3592.

Comerica Bank first reported a position in EVH in Q3 2020 and has held it in 18 quarters since. The position peaked at $2.16M in Q4 2023. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

  • Comerica Bank held 224 shares of Evolent Health worth $894 as of Q4 2025.
  • Comerica Bank sold 742 Evolent Health shares in Q4 2025, an estimated $4.13K.
  • Evolent Health made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3592 holding.
  • Comerica Bank first reported a position in Evolent Health in Q3 2020 and has held it in 18 quarters since.
  • Comerica Bank's Evolent Health position peaked at $2.16M in Q4 2023.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.